Pyxis Oncology, Inc.
PYXS
$2.62
$0.020.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.86M | 76.26M | 88.94M | 105.43M | 126.93M |
| Total Receivables | 700.00K | -- | 3.00M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 586.00K | 5.35M | 6.54M | 4.97M | 761.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.96M | 1.47M | 1.47M | 1.47M | 4.75M |
| Total Current Assets | 72.11M | 83.07M | 99.96M | 111.87M | 132.44M |
|
|
|||||
| Total Current Assets | 72.11M | 83.07M | 99.96M | 111.87M | 132.44M |
| Net Property, Plant & Equipment | 19.42M | 20.10M | 20.77M | 21.45M | 22.14M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 2.43M | 2.49M | 2.54M | 2.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 91.52M | 105.60M | 123.22M | 135.87M | 157.18M |
|
|
|||||
| Total Accounts Payable | 10.89M | 9.76M | 9.41M | 2.85M | 4.86M |
| Total Accrued Expenses | 8.12M | 8.00M | 6.70M | 10.08M | 10.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.69M | 1.63M | 1.57M | 1.51M | 1.45M |
| Total Finance Division Other Current Liabilities | 431.00K | -- | -- | -- | 643.00K |
| Total Other Current Liabilities | 431.00K | -- | -- | -- | 643.00K |
| Total Current Liabilities | 21.13M | 19.38M | 17.68M | 14.43M | 17.68M |
|
|
|||||
| Total Current Liabilities | 21.13M | 19.38M | 17.68M | 14.43M | 17.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.98M | 17.44M | 17.89M | 18.33M | 18.75M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 38.11M | 36.83M | 35.57M | 32.76M | 36.43M |
|
|
|||||
| Common Stock & APIC | 496.53M | 493.78M | 490.72M | 487.77M | 484.14M |
| Retained Earnings | -443.18M | -425.07M | -403.07M | -384.71M | -363.56M |
| Treasury Stock & Other | 53.00K | 69.00K | -5.00K | 49.00K | 170.00K |
| Total Common Equity | 53.41M | 68.78M | 87.64M | 103.10M | 120.75M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.41M | 68.78M | 87.64M | 103.10M | 120.75M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 53.41M | 68.78M | 87.64M | 103.10M | 120.75M |
|
|
|||||